Literature DB >> 28875257

Non-participation in systematic screening for osteoporosis-the ROSE trial.

M J Rothmann1,2, S Möller3, T Holmberg4, M Højberg5,6, J Gram5,7, M Bech8, K Brixen5,9, A P Hermann10,5, C-C Glüer11, R Barkmann11, K H Rubin5,3.   

Abstract

Population-based screening for osteoporosis is still controversial and has not been implemented. Non-participation in systematic screening was evaluated in 34,229 women age 65-81 years. Although participation rate was high, non-participation was associated with comorbidity, aging other risk factors for fractures, and markers of low social status, e.g., low income, pension, and living alone. A range of strategies is needed to increase participation, including development of targeted information and further research to better understand the barriers and enablers in screening for osteoporosis.
INTRODUCTION: Participation is crucial to the success of a screening program. The objective of this study was to analyze non-participation in Risk-stratified Osteoporosis Strategy Evaluation, a two-step population-based screening program for osteoporosis.
METHODS: Thirty-four thousand two hundred twenty-nine women aged 65 to 81 years were randomly selected from the background population and randomized to either a screening group (intervention) or a control group. All women received a self-administered questionnaire designed to allow calculation of future risk of fracture based on FRAX. In the intervention group, women with an estimated high risk of future fracture were invited to DXA scanning. Information on individual socioeconomic status and comorbidity was obtained from national registers.
RESULTS: A completed questionnaire was returned by 20,905 (61%) women. Non-completion was associated with older age, living alone, lower education, lower income, and higher comorbidity. In the intervention group, ticking "not interested in DXA" in the questionnaire was associated with older age, living alone, and low self-perceived fracture risk. Women with previous fracture or history of parental hip fracture were more likely to accept screening by DXA. Dropping out when offered DXA, was associated with older age, current smoking, higher alcohol consumption, and physical impairment.
CONCLUSIONS: Barriers to population-based screening for osteoporosis appear to be both psychosocial and physical in nature. Women who decline are older, have lower self-perceived fracture risk, and more often live alone compared to women who accept the program. Dropping out after primary acceptance is associated not only with aging and physical impairment but also with current smoking and alcohol consumption. Measures to increase program participation could include targeted information and reducing physical barriers for attending screening procedures.

Entities:  

Keywords:  Decline; Non-participation; Osteoporosis; Population-based screening; Women

Mesh:

Year:  2017        PMID: 28875257     DOI: 10.1007/s00198-017-4205-y

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  38 in total

1.  Predictors of bone mineral density testing among older women on Medicare.

Authors:  Y Lou; S W Edmonds; M P Jones; F Ullrich; G L Wehby; P Cram; F D Wolinsky
Journal:  Osteoporos Int       Date:  2016-06-30       Impact factor: 4.507

2.  What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?

Authors:  L van Dam; I J Korfage; E J Kuipers; L Hol; A H C van Roon; J C I Y Reijerink; M van Ballegooijen; M E van Leerdam
Journal:  Eur J Cancer       Date:  2013-04-06       Impact factor: 9.162

3.  Adherence of academic geriatric practitioners to osteoporosis screening guidelines.

Authors:  D N McNally; A M Kenny; J-A Smith
Journal:  Osteoporos Int       Date:  2006-10-17       Impact factor: 4.507

4.  Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease.

Authors:  J A Kanis; P Delmas; P Burckhardt; C Cooper; D Torgerson
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

5.  Costs and quality of life associated with osteoporosis-related fractures in Sweden.

Authors:  Fredrik Borgström; Niklas Zethraeus; Olof Johnell; Lars Lidgren; Sari Ponzer; Olle Svensson; Peter Abdon; Ewald Ornstein; Karl Lunsjö; Karl Göran Thorngren; Ingemar Sernbo; Clas Rehnberg; Bengt Jönsson
Journal:  Osteoporos Int       Date:  2005-11-09       Impact factor: 4.507

Review 6.  Clinical Practice. Postmenopausal Osteoporosis.

Authors:  Dennis M Black; Clifford J Rosen
Journal:  N Engl J Med       Date:  2016-01-21       Impact factor: 91.245

7.  Fracture risk assessed by Fracture Risk Assessment Tool (FRAX) compared with fracture risk derived from population fracture rates.

Authors:  Katrine Hass Rubin; Bo Abrahamsen; Anne Pernille Hermann; Mickael Bech; Jeppe Gram; Kim Brixen
Journal:  Scand J Public Health       Date:  2011-03-23       Impact factor: 3.021

8.  Socioeconomic position and participation in colorectal cancer screening.

Authors:  B L Frederiksen; T Jørgensen; K Brasso; I Holten; M Osler
Journal:  Br J Cancer       Date:  2010-10-19       Impact factor: 7.640

9.  Identifying specific non-attending groups in breast cancer screening--population-based registry study of participation and socio-demography.

Authors:  Line Flytkjær Jensen; Anette Fischer Pedersen; Berit Andersen; Peter Vedsted
Journal:  BMC Cancer       Date:  2012-11-14       Impact factor: 4.430

10.  European guidance for the diagnosis and management of osteoporosis in postmenopausal women.

Authors:  J A Kanis; E V McCloskey; H Johansson; C Cooper; R Rizzoli; J-Y Reginster
Journal:  Osteoporos Int       Date:  2012-10-19       Impact factor: 4.507

View more
  3 in total

Review 1.  Population-Based Osteoporosis Primary Prevention and Screening for Quality of Care in Osteoporosis, Current Osteoporosis Reports.

Authors:  William D Leslie; Carolyn J Crandall
Journal:  Curr Osteoporos Rep       Date:  2019-12       Impact factor: 5.096

2.  Long-term cost-effectiveness of screening for fracture risk in a UK primary care setting: the SCOOP study.

Authors:  E Söreskog; F Borgström; L Shepstone; S Clarke; C Cooper; I Harvey; N C Harvey; A Howe; H Johansson; T Marshall; T W O'Neill; T J Peters; N M Redmond; D Turner; R Holland; E McCloskey; J A Kanis
Journal:  Osteoporos Int       Date:  2020-04-01       Impact factor: 4.507

3.  Utilization of Telemedicine and Visual Presentations to Increase Osteoporosis Evaluation Participation.

Authors:  Vu H Nguyen
Journal:  Geriatr Orthop Surg Rehabil       Date:  2021-05-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.